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SUMMARY
Agglutination of red blood cells, including chicken RBCs (cRBCs), have been used extensively to
estimate viral titer, to screen glycan-receptor binding preference, and to assess the protective
response of vaccines. While enjoying widespread use, it is known that some virus strains do not
agglutinate RBCs. To address these underlying issues and increase the usefulness of cRBCs as
tools to study viruses, such as influenza, we analyzed the cell surface N-glycans of cRBCs. Based
on the results from complementary analytical strategies including mass spectroscopy, 1D and 2D-
NMR spectroscopy, exoglycosidase digestions and HPLC profiling, we report here the major
glycan structures present on cRBCs. By comparing the glycan structures of cBRCs to those of
representative human upper respiratory cells, we offer a possible explanation for the fact that
certain influenza strains do not agglutinate cRBCs, using specific human-adapted influenza
hemagglutinins as examples. Finally, recent understanding of the role of various glycan structures
in high affinity binding to influenza hemagglutinins provides context to our findings [1, 2]. These
results illustrate that the field of glycomics can provide important information with regards to
experimental systems used to characterize, detect, and study viruses.
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INTRODUCTION
Existing assays used to quantify virus isolates and to assess the protective response of
vaccines can be grouped into two categories; assays that “count” virus (or infectious)
particles and assays which measure the binding of a virus particle to a cell, representative of
the first step in the infection cycle. In the former category, assays include the assessment of
plaques formed on a monolayer of mammalian cells, typically MDCK cells, as well as direct
characterization or quantification of viral genome copies through PCR [3–5]. In the latter
category, the most routinely used assay is the hemagglutination assay [6] where the ability
of a given virus to bind to and agglutinate red blood cells (RBCs) is measured.
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In the case of influenza, for example, the hemagglutination assay takes advantage of the fact
that hemagglutinin (HA) on the surface of human-adapted viruses typically binds to specific
sialylated glycans on the surface of epithelial cells of the human upper respiratory tract, the
key first step in the infection cycle [7]. RBCs, also possessing cell surface, sialylated
glycans, act as a surrogate for this binding event. Agglutination of RBCs occurs when
addition of a limiting amount of virus results in “crosslinking” of RBCs through binding of
multiple RBCs to HAs present on a single virus; measurement of various concentrations of
solutions can then be used to quantify viral titer. Additionally, introduction of antisera
capable of neutralizing a viral strain reduces the ability of virus to agglutinate RBCs. In this
manner, the protective effect of vaccines can be assessed. The agglutination assay has a
number of advantages, including rapid turnaround time, easy readout, and benchmarked
results with well-characterized virus strains. These considerable advantages have resulted in
widespread adoption of this assay format.
Given the widespread use of RBCs, specifically those from chicken (cRBCs) as a tool, it is
essential to understand to what extent its glycan repertoire recapitulates the receptors for
human-adapted influenza strains (i.e. glycans of the human upper respiratory tract). This
question becomes especially important in that previous studies have shown that various
human-adapted virus strains and their mutants fail to agglutinate cRBCs. In one study, it was
found that the A/Fujian/411/02 H3N2 virus, responsible for the unusually severe flu season
of 2003–2004, did not efficiently agglutinate cRBCs [8]. This same lack of binding has been
shown for other strains as well [9, 10].
Therefore, through a combination of analytical techniques including MALDI-MS, HPLC,
exoglycosidase treatment, MS/MS and 1D and 2D-HSQC NMR, we report here a detailed
characterization of the N-linked glycans present on the surface of cRBCs. We chose to look
specifically at the N-glycan repertoire due to the fact that we have previously provided
detailed characterization of the N-linked sialylated glycan receptors expressed on the cell
surface of human bronchial epithelial cells (HBE), a natural target for infection by human-
adapted influenza A viruses [11, 12]. By comparing the fine structure attributes such as
degree and extent of branching and relative abundance of α2→3 and α2→6 terminal sialic
acids between cRBCs and HBEs, our study provides insights into the inability of some
human-adapted influenza viruses to agglutinate cRBCs. Defining the glycans present on the
surface of cRBCs will allow for the design of strategies to either optimize the agglutination
assay or design alternative strategies for the detection and quantification of virus strains.
Additionally, we anticipate our strategy to integrate multiple analytical methods can be used
to discern the structure of N-linked glycans obtained from other cell types and thus will
prove useful to interrogate the role of glycans in a variety of disease processes.
RESULTS
To provide a context to our studies, we examined the ability of two well-characterized HAs
from prototypic, pandemic influenza strains, A/South Carolina/1/1918 H1N1 (SC18, 1918
pandemic) and A/Albany/6/1958 H2N1 (Alb58, 1957 pandemic), to agglutinate cRBCs.
These HAs, both from human-adapted, pandemic viruses, have distinct glycan binding
characteristics (Supplemental Fig. S1). While both strains bind with high affinity to a subset
of α2→6 sialyated glycans able to adopt an umbrella topology, associated with human-
adaptation [11, 12], SC18 binding is restricted to only glycans of this type, whereas Alb58
also binds other α2→6 and α2→3 sialyated glycans [13]. In the context of the agglutination
assay, Alb58 HA agglutinated cRBCs at concentrations as low as 6.25 μg/mL
(Supplemental Fig. S2A). Conversely, SC18 HA does not agglutinate cRBCs in the
concentration range tested (up to 400 μg/mL) (Supplemental Fig. S2B). Taken together with
previous reports [8–10], this data indicates that the glycans of cRBCs may not be
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representative of the physiological receptors for human-adapted influenza strains. Therefore,
structural analysis of the cell surface glycans and comparison of these structures to those
present on human upper respiratory epithelium is critical to understand the output of the
agglutination assay, as well as to provide information on its strengths and limitations.
Release and MALDI-MS Analysis of N-Glycans from Chicken Red Blood Cells
N-glycans were isolated from both bovine fetuin, used as a control protein, and from the
surface of chicken red blood cells (cRBCs). PNGase F was used for enzymatic cleavage of
N-glycans as it releases most protein-bound N-linked carbohydrates from animal-derived
cells [14]. Post-purification, but prior to labeling, N-glycans were characterized by
orthogonal analytical techniques including MALDI-MS and NMR.
To obtain preliminary information about the glycan pattern in terms of sugar composition
and possible branching patterns of cRBC glycans, MS profiling was performed. MS-based
strategies offer a sensitive tool to determine glycan composition [15], and the resulting
glycan map provides an overall structural fingerprint of the sample. MALDI-MS analysis of
released N-glycans from cRBCs indicates the presence of a wide range of structures;
tentative assignments of molecular ions are reported in Fig. 1. Additionally, with appropriate
sample work-up and analysis, semi-quantitative information can also be obtained from this
analysis through the use of soft ionization conditions [16], which have been optimized for
the detection of acidic, sialylated structures. To validate the accuracy of the method, analysis
of fetuin N-glycans under identical experimental conditions was performed and compared
with previously reported structures [17] and indicated good agreement, both qualitatively
and quantitatively. This analysis provided us with an overall set of glycan compositions;
additional analyses were performed to extend initial results and provide more detailed
information on the glycan sequence, including linkages and branching patterns.
Analysis of cRBC glycans by 1H NMR
To determine the most relevant glycan sequences for each composition, we completed
additional MS and NMR-based analysis of the cRBC glycan pool. In addition to
identification and quantification of other monosaccharides, we sought to characterize the
overall sialic acid content, to benchmark our analysis to existing studies using lectin staining
[10, 18]. Additionally such an analysis is particularly important with reference to the cRBC/
influenza system, since it is known that human-adapted HAs bind to α2→6 linked sialic
acids, while avian-adapted subtypes bind α2→3-linked sialic acids [19–21].
To obtain quantitative information regarding the sialic acid linkages in cRBCs, we used
separate strategies which together provide overlapping information. First, two different
glycosidases were used to digest glycans – Sialidase S, which cleaves α2→3 and α2→8
linked terminal sialic acid moieties, leaving intact α2→6 linked sialic acid – and Sialidase
A[22], which cleaves α2→3, α2→6, and α2→8 linked sialic acids. In combination with
MALDI MS analysis, enzymatic treatment was used to obtain qualitative information about
the overall distribution of sialic acid linkages among the compositions observed. Secondly,
to obtain quantitative information, NMR spectroscopy was carried out. As above, N-linked
glycans from fetuin were used as a standard sample to assess method accuracy. With fetuin
N-linked glycans, treatment with Sialidase A and Sialidase S and subsequent assessment by
MALDI-MS indicates the presence of a mixture of α2→3 and α2→6 linked sialic acids
(Supplemental Fig. S3), which are evenly distributed across the glycan species. 1H-NMR
spectra of this N-glycan pool indicates the presence of peaks at 1.80 and 1.72 ppm due to the
H3 (axial) proton of α2→3 and α2→6 linked sialic acid, respectively. Integration of these
clearly resolved signals indicates that the amount of α2→3 and α2→6 linked glycans is
approximately 56% and 44%, respectively (Supplemental Fig. S4).
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Fig. 2A shows the MALDI-TOF MS data of Sialidase S-treated cRBC samples. Overall,
these results demonstrate that cRBCs also contain a mixture of α2→3 and α2→6 linked
sialic acids. Three major peaks appeared at 2134.7, 2296.9 and 2499.8 after treatment of the
cRBC N-glycan pool with Sialidase S. The m/z value of 2134.76, a biantennary glycan with
one sialic acid and one bisecting GlcNAc, is likely derived from the parental species at
2426.6 upon release of one sialic acid, suggesting both α2→3 and α2→6 linked sialic acids
are present on the glycan. The m/z value at 2296.9 is representative of a triantennary glycan
with one sialic acid and is likely derived from a parental species with an m/z value of 2880.5
through release of two sialic acid monosaccharides. Alternatively, the same species could be
obtained from m/z of 2589.1 upon release of one sialic acid. In either case partial release of
sialic acid suggests the presence of both α2→3 and α2→6 linked sialic acids on glycan
species within the cRBC pool. Finally, the species at m/z 2499.9, a triantennary glycan with
one sialic acid and with one bisecting GlcNAc, is likely obtained from species at m/z of
2792.2 and 3083.8 by the release of one and two sialic acids, respectively. Quantitative 1H-
NMR analysis of this sample also indicates the presence of a mixture of both α2→3 and
α2→6 linkages, with the peaks at 1.80 and 1.76 ppm due to the H3 (axial) protons and
peaks at 2.69 and 2.64 ppm due to H3 (equatorial) protons with measured integral ratio of
54: 46 (Fig. 2B).
Additional 1H-NMR and 1H-13C HSQC spectroscopic characterization of cRBCs
We also extended our NMR analysis to examine a number of other features within the cRBC
glycan pool which are clearly resolved and can be used to assess overall structure, including
identifying and quantifying the anomeric protons, the H-2 protons of mannose residues, the
H-5 and H-6 protons of fucose residues, the N-acetyl protons of N-acetylglucosamine
(GlcNAc), and the H3-equitorial and H3-axial protons of N-glycolylneuraminic acid
(NeuGc) [23–26]. The 1H-NMR spectrum of cRBCs within the region interest is shown in
Fig. 3 and the list of important chemical shifts, along with a schematic of protons and
probable assignments is shown in Supplemental Table S1. Within the cRBC N-glycan pool,
we detect the presence of several important signatures, including the H-1 anomeric protons,
the H-2 protons of Man (δ 4.05 to 4.25 ppm), and the methyl protons of the N-acetyl groups.
In the spectrum, the presence of sialic acid is confirmed by the detection of a –CH3 signal
around 2.07, proximate to the –CH3 signals for GlcNAc-2 and GlcNAc-7 (Table S1) [27].
Within this same region, the presence of two additional species at 2.03–2.06 ppm are likely
due to –CH3 signals of GlcNAc-5 and GlcNAc-5' and point to the presence of both bi- and
triantennary glycan structures within the cRBC pool. This interpretation was confirmed by
identifying the H-1 and H-2 chemical shifts of mannose monosaccharides within the
spectrum. In this case, the fingerprint chemical shift of the H-2 proton of Manα1→6 at 4.13
arises from mannose in biantennary structures, whereas, the peaks at 4.07 ppm indicate the
presence of H-2 protons of Manα1→6 within tri-antennary structures.
The chemical shifts of the anomeric protons of GlcNAc-2, GlcNAc-5, GlcNAc-5', galactose
(Gal)-6, Gal-6' and Gal-8 appear in the region of 4.40 to 4.75 ppm (see Table S1 for
naming). Specifically, the anomeric proton of GlcNAc-2 appears at 4.62 ppm; the GlcNAc-5
and GlcNAc-5' anomeric protons appear at 4.56–4.59. The signal at 4.54 ppm can be
attributed to the anomeric proton of GlcNAc-7; however, the absence of a signal at 5.56 ppm
(which would be assigned to GlcNAc-7', if present) indicates the relative absence of
tetraantennary structures. According to previous studies[27], the presence of an extended
lactosamine repeat is characterized by signals for the anomeric protons of the two
monosaccharide units - GlcNAc-β and Galβ - at 4.70 and 4.56 ppm, respectively. While
likely absent from the proton spectrum of cRBC glycans, the presence of a prevalent proton
signal from the anomeric position of Man β1→4 necessitated running an HSQC experiment
to resolve this region of the spectrum to determine the presence or absence of signals (see
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below). Taken together, the results from NMR indicate there are likely both bi-, and
triantennary structures within the cRBC N-glycan pool with a mixture of α2→3 and α2→6
linked sialic acids as well as structures containing bisecting GlcNAc.
First, to resolve all signals and ensure accurate quantification of the relative mole% of
different monosaccharides, two-dimensional (2D) 1H-13C HSQC was carried out. As above,
analysis was completed first on the N-glycan pool from bovine fetuin to ensure accuracy of
analysis. The HSQC spectra with volume integration of the anomeric region is shown in
Supplemental Fig. S5. The chemical shift of H-1 of GlcNAc-1 at 5.18 ppm showed a cross
peak with C-1 carbon at ~90 ppm, two dimensional volume integration of this signal was set
to 1.00 as this signal, within the chitobiose core that is common to all N-linked glycans. A
cross peak at 4.62 and 94 ppm is assigned to the GlcNAc-2. Man α1→3showed a cross
peaks at 5.11 and 99 ppm, whereas Man α1→6 showed a cross peaks at 4.8–4.9 and 97 ppm
for H1/C1. Conversely, Man β1→4 showed a cross peak at 4.73–4.77 and ~100 ppm with a
similar integration value. GlcNAc-5 and GlcNAc-5' had cross peaks at 4.57 and 99.2 ppm,
with an integration value of ~2.00, confirm the presence of two protons. Notably, there is no
indication of presence of extra cross peaks at 4.70 which would represent the GlcNAc
portion of a lactosamine repeat.
Next, to obtain detailed structural information of N-glycans from cRBCs, we performed
HSQC analysis of these N-glycans. Because the HSQC spectra of cRBCs displayed similar
cross peak as discussed above for bovine fetuin, analysis was effectively benchmarked and
simplified. In the case of the cRBC glycan pool, cross peaks due to GlcNAc-1, GlcNAc-2,
GlcNAc-5, GlcNAc-5', Manα1→3and Manα1→6 (Fig. 4) appeared in a similar position
with equal integration. The presence of bi-antennary and tri-antennary was also confirmed
by the detection of two different cross peaks at 4.58 and 4.54 ppm and ~99 ppm, due to the
presence of GlcNAc-5&5' and GlcNAc-7 respectively. The cross peak at 4.68 and 99 ppm is
assigned to Manβ1→4. Within the cRBC glycan pool there are no detectable cross peaks of
either GlcNAcβ or Galβ, indicating the absence of repeating lactosamine units.
HPLC profiling of 2-aminobenzamide linked N-glycans mixture from cRBCs
To supplement the structural data obtained on the entire N-glycan pool, we labeled cRBC
glycans with 2-aminobenzamide (2AB), separated them into oligosaccharide pools and
quantified these pools using HPLC. N-glycans from fetuin were labeled and used as a
standard to ensure a standardized analysis. Additionally, to ensure that the labeling reaction
did not result in introduction of sample bias, both labeled and unlabeled cRBC glycans were
profiled on HPLC by pulsed amperometric detection. Comparison of the profiles indicated
no change in the number of peaks nor their relative area (data not shown). Finally, to
calibrate the column with the solvent gradient system (Supplemental Table S2), a glucose
homopolymer ladder is used for calibration. Each detected peak within the ladder is labeled
with a glucose unit (gu) value as shown in Fig. 5A, similar to reported methods [28].
Subsequently, a mixture of three 2AB-labeled N-glycan standards (containing one, two, or
three sialic acids) were used to benchmark the retention times of acidic N-glycans from
cRBCs in our system. Peaks corresponding to these standards appeared between the
retention times of 120–200 min (Fig. 5B). The area under curve for all three peaks are
equivalent to the amount of each glycan injected, consistent with the fact that detection was
largely determined by the label and independent of the attributes of the glycan to which it is
attached. Given this, we sought to determine the amount of individual cRBC glycans by
HPLC through use of a standard curve created by injecting amounts of the three standards
that encompass the ranges of glycans present in the cRBC glycan pool (Supplemental Fig.
S6).
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2AB-labeled N-glycans were qualitatively and quantitatively assessed using this normal
phase HPLC system. The 2AB-labeled glycans from fetuin appear at retention times
between 120 to 200 min and displayed 10 major peaks, which matched the 10 major species
observed through the MALDI-MS profile. Profiling of the cRBC N-glycans showed 12
major peaks in the retention time range of 120–200 min (Fig. 5C). The detailed peak
retention time of each peak including annotation are shown in supplemental Table S3. Based
on the standard curve as shown in Supplemental Fig. S6, the amount of glycan in each peak
was calculated to estimate a percent recovery. The total glycan isolated by HPLC was
calculated to be 91 picomoles (Table S3, ~ 90 % of the injected glycan of 102 picomole).
Taken together with the control experiments outlined above, these results indicate that our
quantitative measurements here can reasonably be correlated with quantitative
measurements on the glycan pool, i.e. NMR and MALDI analysis. To complete the analysis
of N-glycans, three separate, but complementary, approaches were taken. First, pools were
automatically collected and subjected to MS analysis by MALDI TOF. Additionally, we
completed sialidase treatment of the collected pools, to determine the distribution of sialic
acid. Next, we completed on-line MS/MS analysis of the major species; some of these
species were further analyzed by TOF/TOF to ensure accurate structural elucidation.
First, after HPLC profiling, several fractions were collected based on the retention time of
individual peaks and glycans under the peaks and analyzed using MALDI-MS. The various
2AB linked glycans in each peak are shown in Supplemental Table S3. To examine sialic
acid content, sialidase treatment of the 2-AB linked N-glycan pool from cRBCs was
performed (Supplemental Fig. S7). HPLC analysis of the sample after enzymatic treatment
with sialidase S showed that the retention time of some of the peaks remained the same,
indicating no sialic acid cleavage, whereas there was the appearance of new peaks in
retention time window of 5–55 mins (indicating sialic acid cleavage). Integration of the
AUCs for each window confirms the presence of a mixture of α2→3 and α2→6 linked
sialic acids, in a mixture of roughly 50/50, within the cRBC glycan pool.
There are eleven major N-glycan species that are observed in the cRBC pool. Based on their
mass signature, NMR analysis, and enzymatic treatment, the most likely structure for two of
these species, viz., 2135.3 and 2426.6, can be assigned (Table 1). For the rest of the major
species, LC-MS/MS was completed to assign structure. LC-MS/MS of the species with
observed molecular masses of 2500.1, 2792.2, 2880.5, and 3083.8, in combination with the
constraints obtained from the analysis of the N-glycan pool, enabled definitive assignment
(Fig. 6A–D, Table 1). For two of the species, viz., with observed masses of 2297.6 and
2589.1, the fragmentation patterns are consistent with two species, one with a lactosamine
extension and one without (Supplemental Fig. S8). Based on the fact that the NMR analysis,
both mono- and bidimesional, indicated the absence of lactosamine repeats, the most likely
structure for both is the first indicated. To confirm this, TOF/TOF analysis of 2297.6 yielded
a fragmentation pattern consistent with this proposed structure. Taken together, the data thus
strongly supports the structural assignment presented in Table 1.
Comparison of the glycans observed for human bronchial epithelial (HBE) cells with those
present on cRBCs (Table 1) indicates some similarities; for example, both N-glycan pools
have species with m/z signals at ~ 2224.0, 2297.6, 2589.1 and 2880.5. In contrast, many of
the species observed for HBE's (m/z = ~2078.0, 2408.2, 2443.0, 2611.0, 2661.5, 2733.1,
2773.0, 2808.3, 2894.9, 2954.6, 3057.0, and 3097.0)[11] are either completely absent or are
less prominent in cRBCs. Specifically the species with m/z signals at 2808.3, 3057.0 and
3097.0 were previously shown in HBEs to correspond to structures with lactosamine repeats
terminated by sialic acid. Notably, such glycan motifs, polylactosamine extensions
terminated by α2→6 sialic acid, can adopt a distinct umbrella-like topology that governs
high-affinity binding to HA from human-adapted influenza viruses [11]. The most intense
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peak in the analysis of cRBCs, at 2880.9, is present in HBEs as a minor component, and
likely does not represent a structure containing a lactosamine repeat unit. Finally, inspection
of Table 1 indicates that several prominent mass peaks present in cRBCs are absent or less
abundant for HBEs. For example, the peak at m/z 2135.3, represents a biantennary structure
with a bisecting GlcNAc and lack of lactosamine repeats. Thus, beyond the presence of both
α2→3 and α2→6 sialyation, the N-glycans of cRBCs do not recapitulate key properties of
the physiological glycan species encountered by viruses, such as influenza.
DISCUSSION
The widespread use of cRBC agglutination in influenza surveillance and research
necessitates a complete understanding of the structures of the glycan receptors present on the
surface of cRBCs. This is important both for understanding the limitations of the assay and
for better interpretation of the hemagglutination assay results. In this study, distinct
analytical approaches including combining 2D-NMR, HPLC profiling, and MS/MS analysis
were employed to provide detailed structural information on cRBC glycans. Notably, while
we often employed fetuin as a control, the quantitative analysis provided here goes beyond
the several reports of glycans moieties in bovine fetuin [17, 29].
A combination of these analytical techniques showed that the glycan structures on cRBCs
were found to possess both α2→3 and α2→6 linked sialic acid. Significantly, the analysis
revealed an absence of lactosamine repeats, and the presence of bi- and triantennary
structures. This is in contrast to the predominance of α2→6 sialylated glycans with
lactosamine repeats on HBEs, including tetraantennary structures (Table 1). Taken together,
these results indicate that the glycan repertoire of cRBCs is distinct from that of human
upper respiratory cells which are the targets for infection by human adapted influenza A
viruses. These results provide a context to possibly explain why certain human-adapted
influenza strains do not agglutinate RBCs. We note that our analyses here focus on
characterizing the N-linked glycans extracted from cRBCs. In addition to the fact that
previous analysis of HBEs focused on the N-glycan pool, we find that sialylated N-glycans
represent a substantial percentage of total sialylated glycans present on cRBCs. Apart from
the predominantly non-sialylated O-glycans that are a part of ABH blood group antigens,
cRBCs are known to have sialylated O-glycans attached to glycoproteins such as
glycophorins [30]. Most of these sialylated O-linked glycans are terminated by α2→3-
linked sialic acid (typically terminating Core 1-type structure) and hence are likely not
receptors for human-adapted influenza A viruses, which require the presence of α2→6
sialylation.
The difference in the N-linked glycan repertoire of cRBC and human epithelial cells limits
the ability of agglutination assay to assess virus-host binding as highlighted by the results
presented in Supplemental Fig. S1A. In previous studies, SC18 HA has demonstrated
specific high-affinity binding only to 6'SLN-LN, an α2→6 motif with a polylactosamine
repeat that is able to adopt an umbrella topology. On the other hand, while Alb58 also
showed demonstrated high binding affinity to 6'SLN-LN (comparable to SC18 HA), it also
bound to 6'SLN and other α2→3 sialylated glycans (Supplemental Fig. S1B). The observed
difference in the ability of SC18 and Alb58 HA to agglutinate cRBC is explained by
minimal presence of sialylated glycans with poly-lactosamine repeats in the cRBCs. Alb58
on the other hand binds to sialylated glycans with single lactosamines on the cRBCs and
hence shows agglutination.
In summary, our studies have important implications in improving the use of RBC
agglutination assays given that this assay still offers an easy readout for rapid screening.
Using the combination of analytical techniques outlined here, it is possible to obtain fine
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structural characterization of sialylated glycans expressed in RBCs from different sources.
Such a detailed characterization of glycans from different RBCs would permit selection of
the appropriate RBCs to screen avian-adapted and human-adapted viruses. Additionally, it
would also allow for rational engineering of glycan structures on the RBC surface such as
introducing additional enzymes that can generate lactosamine repeats prior to the terminal
sialylation step instead of simply desialylating and resialylated cRBCs.
In addition to improving the use and interpretation of RBC agglutination assay our study
also offers new possibilities for developing focused platforms to determine relative α2→3
and α2→6 sialylated glycan receptor-binding specificity and affinity which has been shown
to be associated with the human adaptation of the influenza virus [11, 12]. Specifically,
knowledge of the fine structure of the sialylated glycans from different cell types would
permit generation of different glycan fractions from these cell types where each fraction
would be characterized in terms of the predominance of a specific terminal sialic acid
linkage and other features such as branch length and extent of branching. These defined
glycan fractions can then be used for developing “natural” glycan array platforms [31] that
can then be used to probe and quantify the binding specificities of HA from avian- and
human-adapted viruses.
MATERIALS AND METHODS
PNGase F (Glycerol Free) was obtained from NE BioLabs. Signal 2-AB Labeling Kit,
Sialidase-A and sialidase-S were obtained from Prozyme. Bovine fetuin, SDS, 2-mercapto
ethanol, acetonitrile, trifluro acetic acid, ATT matrix, Nafion, SP20SS beads and H+ dowex
cation exchanger beads were obtained from Sigma-Aldrich. Calbiosorb beads (Cat. No.
206550) and protease inhibitor cocktail (Cat. No. 53914) were obtained from Calbiochem.
Sep-pak @ C18 columns were obtained from Waters and ENV™-Carb SPE tubes were from
Supelco. C-RBC's were obtained from Rockland Chemicals, and D2O was obtained from
Cambridge Isotope. All commercial reagents were used without further purification.
N-Glycan release by PNGase F from Bovine Fetuin
For many of the assays presented here, bovine fetuin was used as a control, given that its
glycan repertoire is well-characterized [17, 30]. About 1 mg of intact glycoprotein was dried
by lyophilization. To this, 300 μL of purified water was added to make a protein solution of
~3.3 mg/mL. 50 μl of 10X denaturing buffer was added to the vial and incubated in heat
block at 100°C for ~10 minutes. After cooling, 50 μL of both 10X G7 reaction buffer and
10% NP-40 were added to the denatured protein and mixed well. Then 50 μL PNGase F was
added, after which, incubation at 37°C was carried out for about 24 hours. After
deglycosylation, initial clean-up of the released glycans from the protein was completed by
adding 500 μl of Calbiosorb beads to remove SDS. At this point, the sample was further
purified as described below.
Red Blood Cell Surface Glycan Extraction
Glycans were extracted from the surface of cRBCs according to a modified version of a
previously published protocol [11]. cRBCs preparations were diluted in PBS to obtain a
concentration of approximately 400 million cells per mL. The following steps were then
repeated twice; cells were spun down at 2,000g for 10 minutes at 4°C, the supernatant was
aspirated, and the pellet was resuspended in 0.5mL of PBS + 1% protease inhibitor. Cells
were then lysed for 15 minutes under gentle agitation at room temperature in 500 μL of
deionized water containing 1% protease inhibitor. The suspension was then spun down at
2000g for 10 minutes at 4°C and resuspended in 500 μL of PBS + 1% protease inhibitor. An
additional spin down cycle was performed using the same buffer volume at 4,000g for 10
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minutes at 4°C. The supernatant was removed, and the pellet was resuspended in 20μl of
deionized water and 230 μl of an aqueous solution of 1% SDS + 20 mM 2-mercaptoethanol.
The suspended pellets were boiled in a hot water bath for 10 minutes, after which 40 μl of
10% NP40 (PNGase F Kit), 40 μl of G7 Buffer (PNGase F Kit), and 10 μl of PNGase F
were added to the mixture. The pellets were incubated for 24 hours at 37°C under gentle
agitation. After incubation, 100 μl of Calbiosorb beads were added to the mixture to remove
SDS, and this mixture was incubated for 15 minutes under gentle agitation at room
temperature. At this point, the sample was further purified as described below.
Purification of glycans
After digestion with PNGase F, samples were treated with prewashed calbisorb beads,
centrifuged, and the supernatant was added to an equilibrated Sep-Pak C18 column,
according to the manufacturer's instructions. Then, 6 mL of 5% acetonitrile, 0.05% TFA was
used to elute the sample. After lyophilization and drying, the sample was resuspended in 1
mL of water and added to a preequilibrated ENV™-Carb SPE tube. After washing with
0.05% TFA in water, and 5% acetonitrile, 0.05 % TFA in water, N-glycans were eluted in
50% acetonitrile/ water with 0.1% TFA. The purified glycan prep was lyophilized and
reconstituted in 40 μL of water.
2-Amino benzamide (2AB) labeling of N-glycans
Selected N-glycan reactions were fluorescently tagged using the Signal™ 2-AB labeling kit.
Briefly, the reaction was carried out according to the manufacturers' instructions at 65°C for
3 hours. After completion, the samples were purified by using a preequilibrated GlykoClean
G Cartridge. The labeling reaction was added to the column and washed with 96%
acetonitrile/mili-Q water. Labeled glycans were eluted with mili-Q water (6 × 1mL).
Glycan MS Analysis by MALDI-MS spectroscopy
All glycans were analyzed using the Voyager DE-STR MALDI-TOF. The sample and
matrix were combined in a ratio of 1:9, respectively. Nafion (1 μl) was spotted on the plate
and allowed to dry for ~5 minutes. The matrix-sample mixture was then placed on top of the
Nafion spot and allowed to dry in a humidity-controlled chamber (humidity 23%). The
following parameters were used for analysis: negative and linear Mode, 22,000V
Accelerating Voltage, 93% Grid Voltage, 0.3% Guide Wire, 150 nsec Delay. Peaks were
calibrated as non-sodiated species using external glycan standards. Proposed glycan
compositions for each peak were determined by imputing the peak masses into the
GlycoMod software (http://ca.expasy.org/tools/glycomod/), which calculates all
mathematically possible glycan compositions for a given mass.
HPLC analysis of 2AB linked N-glycans using Glyco Sep N column
Labeled glycans were separated and quantified using a Glycosep™ N HPLC column and a
two solvent, gradient system (Solvent A is 100 % acetonitrile; Solvent B is 50 mM
ammonium formate pH 4.4) with UV and fluorescence detection. The gradient table for the
elution of 2AB linked N-glycans from cRBCs including glucose homopolymer and N-
glycan standards is shown in Supplemental Table S2. Prior to the HPLC profiling of N-
glycans from cRBCs, the column and gradient system was verified using Glucose
homopolymer. Furthermore, to obtain accurate retention times for the various N-glycan
species, a standard mixture of known 2AB linked N-glycans (2AB-A1, 2AB-A2 and 2AB-
A3) was injected to the HPLC. Standard N-glycans and those from cRBCs typically eluted
in the 120 to 200 retention time window. The number of peaks and their area under curve
was used for qualitative and quantitative estimation of N-linked structural pools present in
cRBCs. Additionally, during HPLC profiling several fractions were collected. Subsequently,
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solvents were removed by speed-vac and re-suspended with a minimum amount of water,
followed by structural characterization of each individual peaks using MALDI-MS. The
mass peaks obtain from each fraction were also analyzed based on the standard MALDI-MS
GlycoMod software. The possible 2AB linked glycans in each fraction were assessed based
on the N-glycan biosynthesis annotation.
NMR study of N-glycans
The isolated and purified N-glycans were deuterium exchanged using 99 % D2O (three
times) and dried by lyophilization. The dried substance were dissolved in 400 μL of
Deuterium oxide (100 %) and transferred to a 5 mm NMR tube. 1H NMR spectra were
recorded in a Bruker 600 MHz NMR with a cryo-probe using the Topspins program. 2D-
HSQC 1H-13C-NMR spectra were recorded without spinning with the standardized water
frequency O1, p1 (10<P1<16) and D1 (for N-glycans, D1 = 2) values.
Assessment of Sialic Acid Linkages
To purified N-glycan samples, 10 μL of 5X reaction buffer and 7 μL of sialidase A from
Arthrobacter Ureafaciens or Sialidase S from Streptococcus Pneumoniae (Prozyme) was
added and incubated at 37°C for 18 h. The reaction mixture was then heated to 100°C on a
heat block for 5 min to inactivate the enzyme. Subsequently, prior to analysis, the glycans
were purified by micro columns using SP20SS and H+ Dowex Cation Exchanger beads.
Additionally, sialic acid quantification was performed by conversion of the released sialic
acid to pyruvic acid. The released hydrogen peroxide was quantified using standard UV/
fluorescence detection methods. The assay was carried out using the protocol supplied with
the kit. A standard curve obtained using a sialic acid standard was used to quantify detected
sialic acid.
LC-MS/MS Analysis
Unlabeled or 2-AB labeled glycans were subjected to LC-MS analysis. LC was carried out
using an Ultimate 3000 LC system (Dionex) using a C-18 Reverse Phase column (1.8 μm;
2.1mm × 50mm). The mobile phases employed included water/0.1% acetic acid (Solvent A)
and 5% acetonitrile in water with 0.1% acetic acid (Solvent B). A gradient of B over ~60
min was used for N-glycan analysis. The flow-rate used was 250μL/min from the LC
system through a splitter adjusted to obtain a 12μL/min flow into the LTQ ion-trap mass
spectrometer from Thermo Fisher-Scientific. The LTQ MS was operated in positive mode
with ESI voltage of 3.9kV and capillary temperature of 200°C. Triple play data dependent
scanning method was used where 1 MS scan (5 μscans averaged) was followed by a zoom
scan and MSn on the top eight most intense ions. Ions from m/z 480–2000 were selected.
MALDI TOF/TOF
In addition to LC-MS/MS analysis, we also completed TOF/TOF analysis of selected peaks
to confirm structure using MDS Sciex 4800 MALDI TOF/TOF™ instrument and controlled
by the 4000 series explorer™ software. TOF/TOF fragmentation spectra were recorded
using negative-ion linear mode with standardized MS/MS acquisition and processing
methods after tuning of the instrument. TOF/TOF spectra are obtained in 1kV operating
mode with relative resolution of 50 FWHM and laser intensity of 5600 with 400 total shots.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abbreviations used
cRBCs chicken red blood cells
HAs hemagglutinin proteins
MDCK madindarby canine kidney
PCR polymerase chain reaction
MALDI matrix-assisted laser desorption/ionization
SDS sodium dodecyl sulfate
D2O deuterium oxide
TFA trifluoroacetic acid
HSQC heteronuclear single quantum coherence
ATT 6-aza-2-thiothymine
GlcNAc N-acetyl glucosamine
Gal galactose
Man mannose
NeuAc N-acetyl Neuraminic acid
Fuc fucose
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Fig. 1. MALDI-TOF mass spectra of free, non-reduced N-glycans isolated from cRBCs
Peaks appeared in the mass range of 2000 to 3600 with the most prominent peaks at m/z
2589.1 and 2880.5. Each peak was calibrated as a non-sodiated species using external N-
glycan standards as mass calibrants. Proposed glycan structures for each peak using MS
annotation software are shown along with their observed m/z value. The number in the
bracket for each glycan indicates the percentage of each corresponding glycan within the
total glycan pool as estimated by semi-quantitative MALDI MS.
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Fig. 2. Qualitative and quantitative linkage analysis of N-glycans from cRBCs
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(A) MALDI-MS spectra of sialidase S-treated, unlabeled, N-glycans that were released from
cRBCs by PNGase F. (B) 1H-NMR spectra of sialic acid linkage in the free non reduced N-
glycans isolated from cRBCs.
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Fig. 3. 1H-NMR (600 MHZ, D2O) spectra of N-glycans from cRBCs
Landmark chemical shifts are identified for each region of interest. The possible structural
annotations of each monosaccharide fingerprint proton are labeled in the spectrum.
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Fig. 4. HSQC-spectra of N-glycans from cRBCs
The spectrum shows the cross peaks between the anomeric protons (5.25–4.30 ppm) and
carbon (89–105 ppm) signals. The cross peaks confirm the presence of primarily bi- and
triantennary structures. Notably, there is no cross peak detected at around 4.68–4.71 ppm,
indicating the absence of lactosamine repeat units in the cRBC N-glycan pool.
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Fig. 5. HPLC profiling of 2AB-linked N-glycan isolated from cRBCs
Glycans are eluted using a normal phase column with a 50 mM ammonium formate/
acetonitrile gradient as eluant. Total run time is 290 minutes. (A) HPLC profiling of glucose
homo-polymer for calibration of the column. (B) A mixture of three sialic acid containing
N-glycans standards, chosen based on their polarity and molecular weight, are used as
benchmarks. Three different species appeared in the retention time between 120–200 min.
(C) 2-AB labeled N-glycan pool from cRBCs were analyzed within the calibrated and
standardized column system. The acidic N-glycans from cRBCs eluted within the retention
time window of 120–200 minutes. Glycan under each peak was determined from the
MALDI-MS data of the isolated fraction of their corresponding peaks (Table S3).
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Fig. 6. LC-MS/MS data of selected MS peaks of N-glycans from cRBC
Shown are the MS/MS signals of 2-AB labeled structures: (A) 2620; (B) 2911; (C) 3000;
and unlabeled structure: (D) 3083.8. Fragment assignments are shown for each structure.
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Table 1
Structural assignment of the major N-glycans from cRBCs and comparison to those observed in human
bronchial epithelial cells (HBE's).
Theoretical Molecular Mass
Molecular Structure
N-Glycan Source
HBEs cRBCs
2077.7 Present Absent
2134.8 Absent Present
2296.8 Present Present
2422.8 Absent Present
2442.9 Present Absent
2499.9 Absent Present
2571.9 Present Minor
2587.9 Present Present
2734.0 Present Absent
2791.0 Absent Present
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Theoretical Molecular Mass
Molecular Structure
N-Glycan Source
HBEs cRBCs
2808.0 Present Absent
2832.0 Absent Present
2879.0 Minor Present§
2896.0 Present Absent
2953.0 Present Minor
3052.1 Present Absent
3082.1 Absent Present
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